Hand-10 Questionnaire in Children with Unilateral Cerebral Palsy
Launched by GAZI UNIVERSITY · Mar 19, 2025
Trial Information
Current as of April 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a questionnaire called the Hand-10, which helps to assess hand functions in children with unilateral cerebral palsy (CP). The goal is to see if this Turkish version of the Hand-10 is a valid and reliable tool for understanding how well children with CP can use their hands in daily activities. By using pictures and questions, the researchers hope to get a clearer picture of each child's abilities and independence.
To participate, children need to be between 6 and 15 years old and have been diagnosed with unilateral cerebral palsy, meaning they have weakness on one side of their body. They should also be able to understand instructions and have basic reading skills. However, children with other serious health issues, those who don’t use the affected hand, or have had certain surgeries recently will not be eligible. Participants can expect to answer questions that will help researchers learn more about their hand functions and how they manage daily tasks. This study is currently recruiting participants, and it’s a great opportunity to contribute to research that could improve care for children with cerebral palsy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children between the ages of 6-15, diagnosed with unilateral cerebral palsy,
- • With sufficient cognitive status to understand assessment instructions
- • With reading skills
- Exclusion Criteria:
- • Those with health problems not related to cerebral palsy,
- • neglect of the affected extremity,
- • serious visual problems,
- • undergoing botox or orthopedic surgery in the last 6 months,
- • not willing to participate in the study
Trial Officials
Rabia ZORLULAR
Principal Investigator
Gazi University
About Gazi University
Gazi University, a leading research institution based in Ankara, Turkey, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research with clinical practice to explore new therapeutic approaches and enhance existing treatments. Gazi University adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and safety of its clinical trials. By fostering partnerships with healthcare professionals and academic institutions, Gazi University aims to contribute significantly to the global scientific community and address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported